Mineralys Therapeutics, Inc.
MLYS
43 insider filings · Latest: Sep 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Oct 13 8:11 PM | Rodman David Malcom | Proposed Sale | 3,542 | $22.04 | $78.1K | — | View → |
| Sep 30, 2026 | Oct 2 9:53 PM | Jon CongletonDirector, Chief Executive Officer | Sale | 75,000 | $25.46 | $1.9M | 528,621(D) | View → |
| Sep 30, 2026 | Sep 30 8:07 PM | Congleton Jon | Proposed Sale | 75,000 | $25.46 | $1.9M | — | View → |
| Sep 22, 2026 | Sep 25 1:49 AM | Brian Taylor SlingsbyDirector | Sale | 104,320 | $28.81 | $3.0M | 7,805,718(I) | View → |
| Sep 21, 2026 | Sep 22 10:48 PM | Eric WarrenChief Commercial Officer | Sale | 7,438 | $28.12 | $209.1K | 38,400(D) | View → |
| Sep 22, 2026 | Sep 22 8:09 PM | CATALYS PACIFIC FUND LP | Proposed Sale | 104,320 | $28.81 | $3.0M | — | View → |
| Sep 21, 2026 | Sep 21 8:05 PM | Warren Eric | Proposed Sale | 7,438 | $28.12 | $209.1K | — | View → |
| Sep 15, 2026 | Sep 17 9:41 PM | Daphne KarydasDirector | Sale | 3,000 | $28.58 | $85.7K | 6,200(D) | View → |
| Sep 17, 2026 | Sep 17 8:06 PM | Rodman David Malcom | Proposed Sale | 417 | $27.95 | $11.7K | — | View → |
| Sep 15, 2026 | Sep 15 8:19 PM | Karydas Daphne | Proposed Sale | 3,000 | $28.58 | $85.7K | — | View → |
| Sep 14, 2026 | Sep 14 8:06 PM | Rodman David Malcom | Proposed Sale | 7,709 | $28.14 | $216.9K | — | View → |
| Sep 9, 2026 | Sep 9 8:05 PM | Rodman David Malcom | Proposed Sale | 2,171 | $30.87 | $67.0K | — | View → |
| Aug 21, 2026 | Aug 25 9:16 PM | Eric WarrenChief Commercial Officer | Sale | 7,437 | $25.98 | $193.2K | 38,400(D) | View → |
| Aug 21, 2026 | Aug 21 8:14 PM | Warren Eric | Proposed Sale | 7,437 | $25.98 | $193.2K | — | View → |
| Aug 17, 2026 | Aug 17 8:38 PM | Rodman David Malcom | Proposed Sale | 417 | $25.46 | $10.6K | — | View → |
| Aug 13, 2026 | Aug 13 8:12 PM | Rodman David Malcom | Proposed Sale | 14,056 | $26.48 | $372.2K | — | View → |
| Aug 10, 2026 | Aug 12 11:33 PM | David Malcom RodmanChief Medical Officer | Sale | 2,170 | $27.09 | $58.8K | 51,384(D) | View → |
| Aug 10, 2026 | Aug 10 8:39 PM | Rodman David Malcom | Proposed Sale | 2,170 | $27.09 | $58.8K | — | View → |
| Jul 21, 2026 | Jul 23 10:39 PM | Eric WarrenChief Commercial Officer | Sale | 7,438 | $26.87 | $199.9K | 38,400(D) | View → |
| Jul 21, 2026 | Jul 21 8:11 PM | Warren Eric | Proposed Sale | 7,438 | $26.87 | $199.9K | — | View → |
Page 1 of 7
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Apr 16 1:45 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 14,058 | $14.25 | 91,667(D) | View → |
| Apr 9, 2026 | Apr 14 1:13 AM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,170 | $16.00 | 21,706(D) | View → |
| Mar 31, 2026 | Apr 2 10:53 PM | Daphne KarydasDirector | Option Exercise | 3,000 | $12.02 | 41,000(D) | View → |
| Mar 17, 2026 | Mar 17 8:51 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 417 | $15.44 | 5,000(D) | View → |
| Mar 13, 2026 | Mar 16 9:20 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 7,709 | $14.25 | 95,834(D) | View → |
| Mar 12, 2026 | Mar 16 9:20 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 6,348 | $1.08 | 25,395(D) | View → |
| Mar 9, 2026 | Mar 10 9:48 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 2,171 | $16.00 | 23,876(D) | View → |
| Feb 19, 2026 | Feb 21 12:49 AM | RA CAPITAL MANAGEMENT, L.P.Director | Grant/Award | 8,300 | $28.06 | 8,300(I) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Jon CongletonDirector, Chief Executive Officer | Grant/Award | 187,900 | $28.06 | 187,900(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Glenn SblendorioDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Alexander M GoldDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Daphne KarydasDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Other (J) | 8,300 | $28.06 | 0(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Brian Taylor SlingsbyDirector, 10% Owner | Other (J) | 8,300 | $28.06 | 8,300(I) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Srinivas AkkarajuDirector, 10% Owner | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:47 AM | Derek DiroccoDirector | Grant/Award | 8,300 | $28.06 | 8,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:46 AM | David Malcom RodmanChief Medical Officer | Grant/Award | 51,300 | $28.06 | 51,300(D) | View → |
| Feb 19, 2026 | Feb 21 12:46 AM | Adam Scott LevyCFO and Secretary | Grant/Award | 53,300 | $28.06 | 53,300(D) | View → |
| Feb 17, 2026 | Feb 17 11:56 PM | David Malcom RodmanChief Medical Officer | Option Exercise | 417 | $15.44 | 5,417(D) | View → |